跳至主要内容
临床试验/CTRI/2022/03/041364
CTRI/2022/03/041364尚未招募4 期

Study Of Efficacy And Safety Of Oral Minoxidil(2.5MG) V/S Oral Finasteride (1MG) in Male Androgenic Alopecia-A Double Blind Study

Krishna institute of medical sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male patient comes with history or clinical findings suggestive of androgenic alopecia.
  • 2. Age group more than 18 years of age and less than 50 years of age
  • 3. Hamilton grade 2-6
  • 4. Have given written consent before investigation and starting the drug.
  • 5. Be able and willing and fit , in the view of investigator , to comply all study procedures

排除标准

  • 1. Patient who is hypotensive or hypertensive
  • 2. Patients with grade 1 or grade 7 alopecia.
  • 3. Patient with cardiac diseases (including angina, coronary artery disease, recent or acute myocardial infarction, pericardial effusion)
  • 4. Patients with cerebrovascular diseases
  • 5. Patients with deranged liver and kidney function.
  • 6. Patients allergic to finasteride or minoxidil.
  • 7. Patient on any treatment for androgenic alopecia for last 2 months

研究者

相似试验